Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Incidence and Risk Factors for Second Malignancies after Transplant in Long Term Survivors of Allogeneic Haematopoietic Stem Cell Transplant: A Single Centre Experience

Mohammed Snober, Richard Syzdlo, PhD, Jane Apperley, MB ChB MD, Aristeidis Chaidos, MD PhD, Edward Kanfer, PhD, Dragana Milojkovic, MBBS, PhD, Eduardo Olavarria, MD PhD, Renuka Palanicawandar, MD MRCP, FRCPath, Jiri Pavlu, MD MRCP, FRCPath, Jeannie F Todd, PhD, Nina Salooja, MD

Blood (2018) 132 (Supplement 1): 3417.

https://doi.org/10.1182/blood-2018-99-114229

Published: 2018

Journal Articles

Metabolic Syndrome Is Common Following Haematopoietic Cell Transplantation (HCT) and Is Associated with Increased Cardiovascular Disease and Second Cancers: An EBMT Cross-Sectional Non-Interventional Study

Blood (2018) 132 (Supplement 1): 251.

https://doi.org/10.1182/blood-2018-99-116533

Published: 2018

Journal Articles

Conception and Pregnancy Outcomes after Haematopoietic Stem Cell Transplant: A Retrospective Study from the Transplant Complications Working Party of the European Society for Blood and Marrow Transplantation

Blood (2018) 132 (Supplement 1): 2139.

https://doi.org/10.1182/blood-2018-99-113643

Published: 2018

Journal Articles

Provision of Long-Term Monitoring and Late Effects Services Following Hematopoietic Cell Transplantation (HCT): A Survey of European Programs By the Complications and Quality of Life Working Party of the EBMT

Nina Salooja, DM, FRCP, FRCPath, Steffie van der Werf, MSc, Maura Faraci, MD, Angela Hamblin, MDPhD, Anja van Biezen, Grzegorz W. Basak, MD PhD, Rafael F. Duarte, MD PhD

Blood (2016) 128 (22): 4607.

https://doi.org/10.1182/blood.V128.22.4607.4607

Published: 2016

Journal Articles

Outcome of Patients with Second Cancer after Hematopoietic Stem Cell Transplantation: On Behalf of the Complications and Quality of Life Working Party of the EBMT

André Tichelli, MD, Eric Beohou, Myriam Labopin, Gérard Socié, MD PhD, Alicia Rovó, MD, Manuela Badoglio, Anja van Biezen, Grzegorz Basak, MD, Rafael F. Duarte, MD PhD, Nina Salooja, DM, FRCP, FRCPath

Blood (2016) 128 (22): 3441.

https://doi.org/10.1182/blood.V128.22.3441.3441

Published: 2016

Journal Articles

Mortality and Morbidity in 15-Year Survivors of Stem Cell Transplants for Haematological Malignancy

Jack Stuart, Richard Szydlo, PhD, Jane F. Apperley, MD, Jeannie Todd, PhD, Nina Salooja, DM, FRCP, FRCPath

Blood (2015) 126 (23): 4348.

https://doi.org/10.1182/blood.V126.23.4348.4348

Published: 2015

Journal Articles

Androgen Function in Long-Term Survivors of Haematopoietic Stem Cell Transplantation

Jonathon E Topping, Jeannie Todd, PhD, Jane F. Apperley, Nina Salooja, DM, FRCP, FRCPath

Blood (2014) 124 (21): 3957.

https://doi.org/10.1182/blood.V124.21.3957.3957

Published: 2014

Journal Articles

Paternity Wishes in Young Long-Term Survivors After Allogeneic Hematopoietic Stem Cell Transplantation. A Study of the Late Effects Working Party of the EBMT

Alicia Rovo, MD, Mahmoud Aljurf, M.D., Sandra Chiodi, MD, Simonetta Spinelli, MD, Nina Salooja, MD, Gülsan Sucak, MD, Ann E. Hunter, MBBS, FRCP, FRCPath, Tan Swee Kim, MD, Gérard Socié, Maria Teresa van Lint, Jakob R. Passweg, MD, Mutlu Arat, MD, Manuela Badoglio, André Tichelli, MD

Blood (2011) 118 (21): 2002.

https://doi.org/10.1182/blood.V118.21.2002.2002

Published: 2011

Journal Articles

Ongoing Chronic GvHD Is the Most Harmful Factor for Sperm Recovery In Male Survivors After Allogeneic HSCT Not Conditioned with TBI.

Alicia Rovo, MD, Maria Teresa van Lint, MD, Mahmoud Aljurf, MD, Nina Salooja, MD, Gülsan Sucak, MD, Ann Elizabeth Hunter, MD, Tan Swee Kim, MD, Gerard Socie, MD, Manuela Badoglio, Andre Tichelli, MD

Blood (2010) 116 (21): 3449.

https://doi.org/10.1182/blood.V116.21.3449.3449

Published: 2010

Journal Articles

Uptake and Outcome of Artificial Reproductive Techniques Following Allogeneic Stem Cell Tranplantation: A Single Centre Experience.

Anna Babb, Nadine Farah, Jane Apperley, John Goldman, Edward Kanfer, David Marin, Dragana Milojkovic, Amin Rahemtulla, Katy Rezvani, Nina Salooja

Blood (2009) 114 (22): 2257.

https://doi.org/10.1182/blood.V114.22.2257.2257

Published: 2009

Journal Articles

Malignant Neoplasms in Long-Term Survivors of Bone Marrow Transplantation – Follow up

Bernhard Heilmeier, Nadine Stowasser, Gerard Socie, MD, PhD, Maria Teresa van Lint, Andre Tichelli, Nina Salooja, Elke Nekolla, Per T. Ljungman, MD, PhD, Niels Jacobsen, Marie van Weel, Johanna Tischer, Georg Ledderose, Theodor M. Fliedner, Hans-Jochem Kolb

Blood (2008) 112 (11): 453.

https://doi.org/10.1182/blood.V112.11.453.453

Published: 2008

Journal Articles

Monoclonal Gammopathy of Undetermined Significance with an IgE Paraprotein.

Robert M. Ayto, MBBS, Christopher Lambert, BMBS, Irvin Lampert, Nina Salooja

Blood (2007) 110 (11): 4744.

https://doi.org/10.1182/blood.V110.11.4744.4744

Published: 2007

Journal Articles

Nonmalignant late effects after allogeneic stem cell transplantation

Gérard Socié, Nina Salooja, Amnon Cohen, Attilio Rovelli, Enric Carreras, Anna Locasciulli, Elisabeth Korthof, Joachim Weis, Vincent Levy, André Tichelli

Blood (2003) 101 (9): 3373–3385.

https://doi.org/10.1182/blood-2002-07-2231

Published: 2003

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Incidence and Risk Factors for Second Malignancies after Transplant in Long Term Survivors of Allogeneic Haematopoietic Stem Cell Transplant: A Single Centre Experience

Metabolic Syndrome Is Common Following Haematopoietic Cell Transplantation (HCT) and Is Associated with Increased Cardiovascular Disease and Second Cancers: An EBMT Cross-Sectional Non-Interventional Study

Conception and Pregnancy Outcomes after Haematopoietic Stem Cell Transplant: A Retrospective Study from the Transplant Complications Working Party of the European Society for Blood and Marrow Transplantation

Provision of Long-Term Monitoring and Late Effects Services Following Hematopoietic Cell Transplantation (HCT): A Survey of European Programs By the Complications and Quality of Life Working Party of the EBMT

Outcome of Patients with Second Cancer after Hematopoietic Stem Cell Transplantation: On Behalf of the Complications and Quality of Life Working Party of the EBMT

Mortality and Morbidity in 15-Year Survivors of Stem Cell Transplants for Haematological Malignancy

Androgen Function in Long-Term Survivors of Haematopoietic Stem Cell Transplantation

Paternity Wishes in Young Long-Term Survivors After Allogeneic Hematopoietic Stem Cell Transplantation. A Study of the Late Effects Working Party of the EBMT

Ongoing Chronic GvHD Is the Most Harmful Factor for Sperm Recovery In Male Survivors After Allogeneic HSCT Not Conditioned with TBI.

Uptake and Outcome of Artificial Reproductive Techniques Following Allogeneic Stem Cell Tranplantation: A Single Centre Experience.

Malignant Neoplasms in Long-Term Survivors of Bone Marrow Transplantation – Follow up

Monoclonal Gammopathy of Undetermined Significance with an IgE Paraprotein.

Nonmalignant late effects after allogeneic stem cell transplantation

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only